Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

BIOLOGICAL MATERIALS AND USES THEREOF

  • Read more about BIOLOGICAL MATERIALS AND USES THEREOF
US Application 11/066,045
Filed on 2005-02-25

Utilization of Non-viral Sequences For Minus-strand DNA Transfer and Gene Reconstitution

  • Read more about Utilization of Non-viral Sequences For Minus-strand DNA Transfer and Gene Reconstitution
US Application 11/208,436
Filed on 2005-08-19

NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF

  • Read more about NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF
US Application 11/130,545
Filed on 2005-05-16

PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS

  • Read more about PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS
European Patent
05077369.6
Filed on 1998-07-10

Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same

  • Read more about Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same
European Patent
03814012.5
Filed on 2003-12-15

Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same

  • Read more about Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same
Japan
2004-563586
Filed on 2005-06-16

Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same

  • Read more about Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same
Canada
2510309
Filed on 2003-12-15

Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same

  • Read more about Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same
Australia
2003297155
Filed on 2003-12-15

Recombinant Vaccinia Viruses Expressing IL-15 and Methods of Using the Same

  • Read more about Recombinant Vaccinia Viruses Expressing IL-15 and Methods of Using the Same
US Patent 8,663,622
Filed on 2005-11-29

Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells

  • Read more about Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells
Patent Cooperation Treaty
PCT/US05/021253
Filed on 2005-06-16

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1033
  • Page 1034
  • Page 1035
  • Page 1036
  • Page 1037
  • Page 1038
  • Page 1039
  • Page 1040
  • Page 1041
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health